BIOS BioPlus Acquisition Corporation

BioScrip, Inc. (NASDAQ: BIOS) today announced that it has implemented over $7.5 million in annualized cost savings through a reduction in selling and operating expenses. Chairman and CEO, Richard H. Friedman stated, "We identified cost savings opportunities through a newly aligned sales approach that will maximize growth opportunities in new specialty product distribution and will enhance sales of our products and programs to customers. This will also permit us to operate more efficiently, while maintaining the same high quality service levels for which we are known. We were successful in implementing these savings prior to our September 1 target. We believe these cost reductions are a positive step towards returning to profitability and we remain focused on achieving further efficiencies, improving collections and enhancing revenues." About BioScrip, Inc. BioScrip provides comprehensive pharmaceutical care solutions. We partner with healthcare payors, pharmaceutical manufacturers, government agencies, physicians, and patients to deliver cost effective programs that enhance the quality of patient life. We focus our products and services in two core areas: Specialty medication distribution and clinical management services, both nationally and community-based, and Pharmacy Benefit Management services. Our specialty medication distribution capabilities include condition-specific clinical management programs tailored to improve the care of individuals with complex health conditions such as HIV/AIDS, Cancer, Infusion IVIG, Hepatitis C, Rheumatoid Arthritis, Multiple Sclerosis, and Transplantation. Our complete pharmacy benefit management programs include customized benefit plan design, pharmacy network management and sophisticated reporting capabilities that deliver improved clinical and economic outcomes. In addition, we have 36 locations including community and infusion pharmacies in major metropolitan markets across the U.S., providing nationwide access and clinical management capabilities in a high-touch community-based environment. Forward Looking Statements This press release may contain statements which constitute forward looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the intent, belief or current expectations of the Company, its directors, or its officers with respect to the future operating performance of the Company and our success with respect to the integration and consolidation. Investors are cautioned that any such forward looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those in the forward looking statements as a result of various factors. Important factors that could cause such differences are described in the Company's periodic filings with the Securities and Exchange Commission.